Nolato AB (publ) (NOLA-B) - Net Assets

Latest as of December 2025: Skr5.53 Billion SEK ≈ $595.33 Million USD

Based on the latest financial reports, Nolato AB (publ) (NOLA-B) has net assets worth Skr5.53 Billion SEK (≈ $595.33 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr9.28 Billion ≈ $998.89 Million USD) and total liabilities (Skr3.75 Billion ≈ $403.56 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nolato AB (publ) asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr5.53 Billion
% of Total Assets	59.6%
Annual Growth Rate	9.95%
5-Year Change	16.02%
10-Year Change	199.03%
Growth Volatility	10.3

Nolato AB (publ) - Net Assets Trend (2002–2025)

This chart illustrates how Nolato AB (publ)'s net assets have evolved over time, based on quarterly financial data. Also explore NOLA-B total asset value for the complete picture of this company's asset base.

Annual Net Assets for Nolato AB (publ) (2002–2025)

The table below shows the annual net assets of Nolato AB (publ) from 2002 to 2025. For live valuation and market cap data, see Nolato AB (publ) market cap and net worth.

Year	Net Assets	Change
2025-12-31	Skr5.53 Billion ≈ $595.33 Million	-3.59%
2024-12-31	Skr5.74 Billion ≈ $617.50 Million	+10.96%
2023-12-31	Skr5.17 Billion ≈ $556.48 Million	-4.10%
2022-12-31	Skr5.39 Billion ≈ $580.27 Million	+13.09%
2021-12-31	Skr4.77 Billion ≈ $513.11 Million	+28.90%
2020-12-31	Skr3.70 Billion ≈ $398.07 Million	+24.71%
2019-12-31	Skr2.97 Billion ≈ $319.19 Million	+14.43%
2018-12-31	Skr2.59 Billion ≈ $278.94 Million	+20.06%
2017-12-31	Skr2.16 Billion ≈ $232.34 Million	+16.70%
2016-12-31	Skr1.85 Billion ≈ $199.09 Million	+5.17%
2015-12-31	Skr1.76 Billion ≈ $189.30 Million	+12.25%
2014-12-31	Skr1.57 Billion ≈ $168.63 Million	+16.25%
2013-12-31	Skr1.35 Billion ≈ $145.07 Million	+11.87%
2012-12-31	Skr1.21 Billion ≈ $129.68 Million	+4.69%
2011-12-31	Skr1.15 Billion ≈ $123.87 Million	-2.37%
2010-12-31	Skr1.18 Billion ≈ $126.88 Million	+8.56%
2009-12-31	Skr1.09 Billion ≈ $116.87 Million	+2.65%
2008-12-31	Skr1.06 Billion ≈ $113.86 Million	+20.09%
2007-12-31	Skr881.00 Million ≈ $94.81 Million	+11.66%
2006-12-31	Skr789.00 Million ≈ $84.91 Million	-5.17%
2005-12-31	Skr832.00 Million ≈ $89.54 Million	+27.02%
2004-12-31	Skr655.00 Million ≈ $70.49 Million	+15.11%
2003-12-31	Skr569.00 Million ≈ $61.23 Million	-8.81%
2002-12-31	Skr624.00 Million ≈ $67.15 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Nolato AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	Skr5.53 Billion	100.00%
Total Equity	Skr5.53 Billion	100.00%

Nolato AB (publ) Competitors by Market Cap

The table below lists competitors of Nolato AB (publ) ranked by their market capitalization.

Company	Market Cap
Guilin Fuda Co Ltd SHG:603166	$1.29 Billion
Youcare Pharmaceutical Group Co. Ltd. A SHG:688658	$1.29 Billion
Fujian Aonong Biological Technology Group Incorporation Ltd SHG:603363	$1.29 Billion
Ardent Health Partners, Inc. NYSE:ARDT	$1.29 Billion
Shaanxi Provincial Natural Gas Co Ltd SHE:002267	$1.29 Billion
Savers Value Village, Inc. NYSE:SVV	$1.29 Billion
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	$1.29 Billion
Forestar Group Inc NYSE:FOR	$1.29 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nolato AB (publ)'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 5,738,000,000 to 5,532,000,000, a change of -206,000,000 (-3.6%).
Net income of 777,000,000 contributed positively to equity growth.
Other comprehensive income decreased equity by 773,000,000.
Other factors decreased equity by 210,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr777.00 Million	+14.05%
Other Comprehensive Income	Skr-773.00 Million	-13.97%
Other Changes	Skr-210.00 Million	-3.8%
Total Change	Skr-	-3.59%

Book Value vs Market Value Analysis

This analysis compares Nolato AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.42x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 19.45x to 2.42x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2002-12-31	Skr2.55	Skr49.60	x
2003-12-31	Skr2.16	Skr49.60	x
2004-12-31	Skr2.49	Skr49.60	x
2005-12-31	Skr3.16	Skr49.60	x
2006-12-31	Skr3.00	Skr49.60	x
2007-12-31	Skr3.35	Skr49.60	x
2008-12-31	Skr4.02	Skr49.60	x
2009-12-31	Skr4.13	Skr49.60	x
2010-12-31	Skr4.48	Skr49.60	x
2011-12-31	Skr4.38	Skr49.60	x
2012-12-31	Skr4.58	Skr49.60	x
2013-12-31	Skr5.12	Skr49.60	x
2014-12-31	Skr5.96	Skr49.60	x
2015-12-31	Skr6.69	Skr49.60	x
2016-12-31	Skr7.03	Skr49.60	x
2017-12-31	Skr8.20	Skr49.60	x
2018-12-31	Skr9.82	Skr49.60	x
2019-12-31	Skr11.22	Skr49.60	x
2020-12-31	Skr13.88	Skr49.60	x
2021-12-31	Skr17.74	Skr49.60	x
2022-12-31	Skr20.02	Skr49.60	x
2023-12-31	Skr19.20	Skr49.60	x
2024-12-31	Skr21.30	Skr49.60	x
2025-12-31	Skr20.54	Skr49.60	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nolato AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 14.05%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 8.21%
• Asset Turnover: 1.02x
• Equity Multiplier: 1.68x
Recent ROE (14.05%) is below the historical average (17.18%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2002	9.62%	2.98%	1.06x	3.04x	Skr-2.40 Million
2003	6.15%	1.31%	1.46x	3.22x	Skr-21.90 Million
2004	19.85%	5.41%	1.50x	2.44x	Skr64.50 Million
2005	21.75%	8.02%	1.35x	2.00x	Skr97.80 Million
2006	6.08%	1.78%	1.57x	2.19x	Skr-30.90 Million
2007	17.03%	6.20%	1.26x	2.18x	Skr61.90 Million
2008	16.82%	6.30%	1.33x	2.01x	Skr72.20 Million
2009	11.33%	4.73%	1.23x	1.95x	Skr14.40 Million
2010	15.86%	5.54%	1.44x	1.99x	Skr69.10 Million
2011	11.47%	4.43%	1.39x	1.86x	Skr16.90 Million
2012	16.76%	5.21%	1.47x	2.19x	Skr81.50 Million
2013	23.29%	6.94%	1.76x	1.91x	Skr179.20 Million
2014	23.23%	8.60%	1.45x	1.86x	Skr207.30 Million
2015	23.88%	8.89%	1.46x	1.84x	Skr244.10 Million
2016	18.16%	7.56%	1.13x	2.12x	Skr151.00 Million
2017	26.49%	8.51%	1.41x	2.20x	Skr356.10 Million
2018	27.85%	8.91%	1.57x	1.99x	Skr462.80 Million
2019	23.70%	8.88%	1.29x	2.07x	Skr406.40 Million
2020	21.79%	8.61%	1.08x	2.35x	Skr436.10 Million
2021	24.33%	9.99%	1.15x	2.11x	Skr683.20 Million
2022	12.93%	6.47%	1.08x	1.86x	Skr157.80 Million
2023	8.41%	4.56%	1.03x	1.80x	Skr-82.10 Million
2024	11.47%	6.81%	1.00x	1.69x	Skr84.20 Million
2025	14.05%	8.21%	1.02x	1.68x	Skr223.80 Million

Industry Comparison

This section compares Nolato AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $767,843,049
Average return on equity (ROE) among peers: -54.63%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Nolato AB (publ) (NOLA-B)	Skr5.53 Billion	9.62%	0.68x	$1.29 Billion
Acarix A/S (ACARIX)	$82.14 Million	-50.58%	0.10x	$33.84 Million
Arcoma AB (ARCOMA)	$12.52 Million	-92.85%	4.66x	$11.55 Million
Bactiguard Holding AB (publ) (BACTI-B)	$140.95 Million	-2.42%	4.09x	$61.64 Million
BICO Group AB (BICO)	$6.93 Billion	-12.06%	0.47x	$159.82 Million
Boule Diagnostics AB (BOUL)	$269.30 Million	-17.81%	0.78x	$14.38 Million
CellaVision AB (CEVI)	$113.42 Million	33.81%	0.43x	$311.10 Million
Clinical Laserthermia Systems AB (publ) (CLS-B)	$31.58 Million	-56.50%	0.17x	$11.57 Million
Chordate Medical Holding AB (CMH)	$9.20 Million	-296.39%	0.91x	$29.05K
C-Rad AB (publ) (CRAD-B)	$83.33 Million	-16.56%	0.89x	$86.08 Million
Duearity AB (DEAR)	$3.79 Million	-34.93%	0.15x	$331.97K

About Nolato AB (publ)

ST:NOLA-B Sweden Medical Devices

Market Cap

$1.29 Billion

Skr11.99 Billion SEK

Market Cap Rank

#8012 Global

#118 in Sweden

Share Price

Skr49.60

Change (1 day)

+1.54%

52-Week Range

Skr46.90 - Skr63.75

All Time High

Skr109.65